https://www.selleckchem.com/products/mrtx1719.html
LncRNA LINC01255 is highly expressed in bone marrow cells of AML patients, CD34+ cells of MDS-AML patients and AML cell lines and the higher expression of LINC01255 is associated with poor survival rate of AML patients. LINC01255 can interact with BMI1 and repress the transcription of MCP-1 to active p53-p21 pathway, thus inhibiting the senescence of human mesenchymal stromal and proliferation of acute myeloid leukemia cell. We discovered a novel functional lncRNA LINC01255, which can regulate the senescence of human mesenchymal stroma
Like
Comment
Share
